About Yozma
Yozma is a venture capital firm founded in 1993. It is primarily based out of Ramat Gan, Israel. As of Nov 2021, Yozma has invested in 23 companies. It primarily invests in Series B round in Israel based startups. Its investments are spread across a wide range of sectors from Life Sciences to High Tech and Transportation and Logistics Tech. Most recently it participated in the $***** Series B round of Illumigyn Overall, Yozma portfolio has seen 1 unicorn, 5 IPOs and 5 acquisitions including key companies like Alpha Tau Medical, StoreDot and Can-Fite. Ubicom Holdings co-invest with Yozma, sharing a substantial percentage of its portfolio. Yozma has team of 4 people including 3 partners.Key Metrics
Team Members
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Unattributed, Post IPO & 2 more
Portfolio IPOs
Portfolio Unicorns
Yozma's List of Top Investments
Yozma has a portfolio of 23 companies, one of which is a Unicorn. Their most notable investmentis in ComoTheir portfolio spans across Israel, United States, South Korea and 1 more locations. They have invested in Life Sciences, High Tech, Transportation and Logistics Tech and 14 other sectors, across stages such as Unattributed, Post IPO and 2 more. Here is the list of top investments by Yozma:Developer of radiotherapy technique for the treatment of solid cancer tumors. The technology, known as Alpha DaRT treats solid tumors with interstitial radioactive seeds which release short-lived alpha-emitting atoms into the tumor continuously. This treatment does not have any effect on the surrounding healthy tissue.
Key facts about Alpha Tau Medical
- Founded Year: 2015
- Location: Tel Aviv (Israel)
- Stage: Public
- Total Funding till date: $55M
- Employee Count: 81 as on Jul 01, 2024
- Investors: Regah Ventures, OurCrowd and 15 Others
- Latest Funding Round: Post IPO, Apr 29, 2025, $*****
- Highlight: Public
2. StoreDot
Manufacturer of fast charging batteries for electric vehicles. The company develops lithium batteries by combining nanostructural materials with organic binders and electrolytes to offer optimized batteries for multiple sectors.
Key facts about StoreDot
- Founded Year: 2012
- Location: Herzliya (Israel)
- Valuation: $*****
- Stage: Series D
- Total Funding till date: $226M
- Employee Count: 208 as on Mar 31, 2026
- Investors: EG Capital Advisors, Amplefields Investments and 35 Others
- Latest Funding Round: Series D, May 24, 2022, $*****
- Highlight: Editors' Pick
3. Can-Fite
Key facts about Can-Fite
- Founded Year: 1994
- Location: Petah Tikva (Israel)
- Stage: Public
- Total Funding till date: $25.5M
- Employee Count: 9 as on Jul 01, 2024
- Investors: Swanlaab USA, Yozma and 4 Others
- Latest Funding Round: Post IPO, Dec 20, 2021, $*****
- Highlight: Public
SCM Lifescience develops stem cell therapeutics and related services. The company uses a proprietary subfractionation culturing method (SCM) to isolate mesenchymal stem cells (MSCs) from adipose tissue, bone marrow and periodontal ligaments. The procedure produces MSCs that are non-immunogenic in nature, and thus can be used as universal donor cells. SCM is investigating MSC therapeutics for indications like immune-related or inflammatory diseases such as graft-versus host disease, atopic dermatitis and pancreatitis. In addition, the company also offers CMO services for stem cell production and clonal stem cell banking services.
Key facts about SCM Lifescience
- Founded Year: 2014
- Location: Incheon (South Korea)
- Stage: Public
- Total Funding till date: $4.8M
- Employee Count: 8 as on Jul 01, 2024
- Investors: Shinhan Venture Investment, Yozma and 5 Others
- Latest Funding Round: Series A, Oct 26, 2018, $*****
- Highlight: Public
Minovia provides cell therapy treatment for mitochondrial disease. The company uses Mitochondria Augmentation Therapy (MAT) a proprietary method of isolating mitochondria from white blood cells or placentas. The placental blood of women is used to extract mitochondria, then the cell collection is done, and after that apheresis where doctors can select hematopoietic stem cells from the white blood cells collected and then, over 24 hours, introduce the healthy mitochondria to the stem cells.
Key facts about Minovia Therapeutics
Yozma's Year-on-Year Investment Trends
Yozma has invested in 23 companies over the last 32 years, with an average of 0 new investment annually in the last 10 years. Its most recent first time investment was in Illumigyn and most recent follow-on round was in X-Technologies.Yozma's Investments by Stage
Yozma has made 2 investments in Unattributed stage with an average round size of $1.2M, 1 investment in Post IPO stage with an average round size of $3.4M, 1 investment in Seed stage with an average round size of $1.5M and 1 investment in Series B stage with an average round size of $33M.Stage of entry | No. of Investments |
|---|---|
Unattributed | 2 |
Post IPO | 1 |
Seed | 1 |
Series B | 1 |
Note: We have considered here, only first round of investments
Yozma's Investments by Sector
Yozma has a diverse portfolio, with companies operating in the Life Sciences, Enterprise Applications, High Tech, Retail and Sustainability Tech. Notably, it has invested in 14 Enterprise (B2B) companies, 13 Tech companies, 6 Software companies and at least 4 companies focusing on Tech hardware.Sector | No. of Investments |
|---|---|
Life Sciences | 3 |
Enterprise Applications | 1 |
High Tech | 1 |
Retail | 1 |
Sustainability Tech | 1 |
Note: We have considered here, only first round of investments
Yozma's Investments by Geography
Yozma has made most investments in Israel (4), followed by United States where it has made 1 investment.Country | No. of Investments |
|---|---|
Israel | 4 |
United States | 1 |
Note: We have considered here, only first round of investments
Yozma's recent investments
Yozma has not made any investment in 2026 so far.Here are the most recent investments by Yozma:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Nov 03, 2021 | Israel | Series B | 6401 | ||
Jan 25, 2021 | Israel | Post IPO | 5851 | - | |
2006 | United States | Seed | 1511 | - | |
Nov 20, 2001 | Israel | Series B | 4295 | [+1] | |
Aug 03, 2000 | Israel | Series A | 5034 |
Unicorns in Yozma's Portfolio
Yozma has 1 unicorn in its portfolio - StoreDot. The most recent unicorn in their portfolio is StoreDot which became a unicorn in 2022, 4 years before Yozma first invested in it.Here is a list of unicorns in Yozma's portfolio:
Tracxn Score | Company | Short Description | Founded year | Sector | Location | Company Stage | First Investment/ Acquisition Details |
|---|---|---|---|---|---|---|---|
64 | Manufacturer of fast charging batteries for electric vehicles | 2012 | Herzliya | Series D | kghxqmf |
IPOs and Publicly Listed companies in Yozma's Portfolio
5 of Yozma's portfolio companies have become public. Alpha Tau Medical got listed on the National Association of Securities Dealers Automated Quotations (NASDAQ), in Mar 2021 and SCM Lifescience got listed on the Korea Exchange (KRX) at marketcap of $154M.Here are Yozma's portfolio companies that went public:
Company | IPO Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Mar 08, 2021 | - | - | 8782 | |
Jun 17, 2020 | - | - | 4948 | |
Aug 24, 2017 | Jan 25, 2021 | Post IPO | 4676 | |
Nov 19, 2013 | - | - | 2442 | |
Jun 10, 2004 | - | - | 6496 |
Acquired companies in Yozma's Portfolio
5 companies from Yozma's portfolio have been acquired. The most recent acquisition were Imvision in Dec 2021 by Intuit for $50M.Here are Yozma's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Dec 23, 2021 | - | - | 7317 | |
Sep 08, 2006 | - | - | 8714 | |
Jan 01, 2004 | - | - | 3001 | |
Mar 10, 2003 | 1999 | Unattributed | 4509 | |
Oct 12, 1999 | Mar 1994 | Unattributed | 2979 |
Team profile of Yozma
Yozma has a team of 4 members including 3 Partners and 1 Venture Partner located in Israel. Yozma's team does not sit on the board of any company as of now.Here is a list of all team members in Yozma:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Israel | - | ||
Partner | Tel Aviv Yafo | - | - | |
Partner | - | - | - | |
Venture Partner | Israel | - | - |
Co-investors of Yozma
Over the past 32 years, 9 investors have co-invested in Yozma's portfolio companies. This includes funds and angels.
- Invested before Yozma: EIC Fund, Europa and 1 other have invested in rounds before Yozma. There is 1 company where EIC Fund has invested before Yozma and 1 company where Europa has invested before Yozma.
- Top Co-investors of Yozma: Ubicom Holdings entered a company along with Yozma.
- Invested after Yozma: A total of 5 investors have invested in Yozma's portfolio after their investments. Top Investors include Benchmark (1 company), J P Morgan (1 company) and ABS Ventures (1 company).
Recent News related to Yozma
•
Todos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note HoldersGlobeNewswire•Mar 14, 2023•Todos Medical, Yozma
•
•
UltraSight Raises $13M to Bring AI-Guided Cardiac Ultrasound to Point of CareHIT Consultant•May 11, 2021•UltraSight, Yozma, Weizmann Institute of Science, Atain Insurance Companies and 1 other
•
Busan City Signs Agreement with Yozma Group to Foster Innovative StartupsBusinesskorea•Apr 14, 2021•Yozma
•
•
Yozma Group Korea invests $3.4M in Israeli firm Todos MedicalBioSpectrum Asia•Jan 29, 2021•Yozma, Todos Medical
•
Israeli startup SixAI signs strategic partnership in South KoreaCTech•Jan 19, 2021•Sixai, ISC Co, Yozma
•
•
Nano-X Imaging prices upsized IPO at $18, trading starts todaySeeking Alpha•Aug 21, 2020•Nanox, Cantor Fitzgerald, Oppenheimer, Berenberg and 6 others
•
Nano-X Imaging Raises USD110M in Equity FundingFinSMEs•Jul 28, 2020•Nanox, SK Telecom, Foxconn Electronics, Yozma and 3 others
